CacheBy
Thermo Fisher Scientific Cetuximab Chimeric Recombinant Mouse Monoclonal Antibody (C225 (Cetuximab))
원본

Thermo Fisher Scientific Cetuximab Chimeric Recombinant Mouse Monoclonal Antibody (C225 (Cetuximab))

상품 한눈에 보기

EGFR을 표적으로 하는 키메라형 마우스 단일클론 항체로, Flow Cytometry 및 Inhibition Assay에 사용 가능. HEK293 세포에서 발현된 재조합 항체이며, 단백질 A로 정제됨. 연구용으로만 사용 가능하며, 4°C 단기 보관 및 -20°C 장기 보관 권장.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 05. 오전 07:17
Thermo Fisher Scientific MA551718 Cetuximab Chimeric Recombinant Mouse Monoclonal Antibody (C225 (Cetuximab)) 200 ug pk판매 단위 pk ·
재고 확인 필요
873,900원VAT 포함 961,290원

Thermo Fisher Scientific · Thermo Fisher Scientific Cetuximab Chimeric Recombinant Mouse Monoclonal Antibody (C225 (Cetuximab))

Applications

Flow Cytometry (Flow)

  • Tested Dilution: Assay-dependent

Inhibition Assays (IA)

  • Tested Dilution: Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Host / Isotype Mouse / IgG1, kappa
Expression System HEK293 cells
Class Recombinant Monoclonal
Type Antibody
Clone C225 (Cetuximab)
Immunogen The epidermal growth factor receptor is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands.
Conjugate Unconjugated
Form Liquid
Concentration 1 mg/mL
Purification Protein A
Storage Buffer PBS
Contains 0.02% ProClin 300
Storage Conditions Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Shipping Conditions Wet ice

Target Information

Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer, and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.